Delivery Order SPE2DE24D0021-SPE2D625F2MZQ
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,127.14 on August 5, 2025, for tri-valent swab negative control products (5-pack) under a fixed-price contract with economic price adjustment provisions. The contract is set to be completed by August 8, 2025, with performance taking place in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger procurement vehicle and was awarded without set-aside designation through open competition. The...
- The U.S. Department of Defense Medical Supply Chain (DLA Troop Support) awarded a $1,040.12 fixed-price delivery order contract to Fisher Scientific Company L.L.C. for the procurement of tri-valent swab negative control items. This contract was issued under an existing Multiple Award Schedule (MAS) vehicle and does not utilize a set-aside designation. Fisher Scientific, a major supplier of scientific products and laboratory equipment, will provide these supplies to support the agency's testing...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,953.78 by the Defense Medical Supply Chain on August 14, 2025, for the supply of vaginal positive control material in 6x0.9ml units. The contract, which employs fixed-price pricing with economic price adjustment terms, carries a completion date of August 21, 2025, and will be performed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was made through open competition with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,445.75 on August 21, 2025, by the Medical Supply Chain, a defense-oriented federal agency. The contract, which uses fixed price with economic price adjustment pricing, covers the supply of National Influenza/Respiratory Syncytial Virus/COVID-19 positive control materials in 6x0.5mL format for research use only (RUO). This is a child contract with no set-aside designation, indicating open competition procurement....
- The U.S. Department of Defense's Medical Supply Chain, also known as VPDLATSMED-A, awarded a firm-fixed-price delivery order contract to Fisher Scientific Company L.L.C. for the delivery of tri-valent swab negative controls in a pack of 5. The contract has a ceiling value of $1,026.08 and an ultimate completion date of December 24, 2024. This order is placed under an indefinite delivery vehicle (IDV) contract, likely the Multiple Award Schedule (MAS) contract, which allows the government to...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,376.30 for vaginal negative control samples (6 x 0.9 mL per unit) on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract employs a fixed-price pricing structure with economic price adjustment provisions and will be performed in Pittsburgh, Pennsylvania. This delivery order is issued under a larger contract vehicle and represents a pediatric purchase without set-aside designation,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,768.64 on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. This fixed-price contract with economic price adjustment provisions is scheduled for ultimate completion by September 11, 2025, and will be performed in Pittsburgh, Pennsylvania. The delivery order was awarded through open competition with no set-aside designation, reflecting Fisher Scientific's competitive standing as a major...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 15, 2025, by the Medical Supply Chain division of the Department of Defense for the procurement of quality control slide gram stain controls in a 45-pack configuration. The contract carries a ceiling value of $1,405.06 and is structured as a fixed-price delivery order with economic price adjustment provisions. Performance will be executed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 22, 2025....
- Fisher Scientific Company L.L.C. was awarded a delivery order contract valued at $1,100.12 by the Defense department's Medical Supply Chain on July 29, 2025, for respiratory viral testing supplies, specifically nasopharyngeal swabs. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of August 5, 2025. Performance will take place in Pittsburgh, Pennsylvania. This award represents a child contract under a...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,619.50 by the Medical Supply Chain, a defense-focused federal agency, on July 31, 2025. The award covers the procurement of FINTIP FLT STR 200UL 960CS products, with performance scheduled for completion by August 5, 2025, at the company's Pittsburgh, Pennsylvania location. This contract utilizes a fixed price with economic price adjustment pricing structure and was awarded through open competition with no set-aside...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F2MZQDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,690.71 on September 4, 2025, for the supply of tri-valent swab negative controls in a five-pack configuration. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by September 9, 2025, and will be performed in Pittsburgh, Pennsylvania. This award was issued by the Medical Supply Chain, a defense-focused federal agency, with no set-aside designation applied. As a child contract under a larger vehicle, this delivery order leverages Fisher Scientific's established position as a critical vendor of laboratory and medical supplies to federal government agencies. Fisher Scientific, registered in SAM.gov since 2001, brings extensive expertise in providing specialized laboratory and medical equipment across multiple federal departments. The tri-valent swab negative controls being procured under this delivery order represent quality assurance and diagnostic testing supplies essential for laboratory validation and testing protocols. The company's demonstrated track record with defense and civilian agencies, combined with its comprehensive capabilities in scientific supply chain management, positions it to effectively deliver these specialized diagnostic control materials within the specified timeframe and performance location.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/4/25 |